Sheets Smith Wealth Management ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock) - 13F, 13D, 13G Filings

Novartis AG - 예탁증서(보통주)

DE ˙ DB ˙ US66987V1098

€121.00 0.00 (0.00%)

2026-06-04
주가

Security	DE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
Institution	Sheets Smith Wealth Management
Latest Disclosed Ownership	2,450 shares
Latest Disclosed Value	$ 374,238

Sheets Smith Wealth Management ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 16, 2026 - Sheets Smith Wealth Management filed a 13F-HR form disclosing ownership of 2,450 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $314,825 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 2,450 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $296,450 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-16	2026-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	374	10.98	0.0421
2026-01-20	2025-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	338	7.32	0.0371
2025-10-16	2025-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	314	6.08	0.0356
2025-07-15	2025-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	296	8.42	0.0347
2025-04-23	2025-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	273	14.71	0.0339
2025-01-17	2024-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	238	-15.30	0.0291
2024-11-01	2024-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	282	8.08	0.0345
2024-07-30	2024-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	-175	-6.67	261	2.77	0.0312
2024-05-08	2024-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,625	175	7.14	254	2.43	0.0284
2024-02-06	2023-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	247	-0.80	0.0352
2023-10-23	2023-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	250	0.81	0.0380
2023-08-09	2023-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	247	9.78	0.0361
2023-05-26	2023-03-31	13F/A-1	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	225	1.35	0.0344
2023-05-12	2023-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	92	-2,358		225		0.0345
2023-03-08	2022-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	2,450		222		0.0348
2022-11-01	2022-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	0	-2,450	-100.00	0	-100.00
2022-07-27	2022-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	207	-3.72	0.0341
2022-05-02	2022-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	215	0.47	0.0296
2022-01-20	2021-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	214	7.00	0.0266
2021-10-15	2021-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	0	0.00	200	-10.71	0.0271
2021-08-03	2021-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,450	-80	-3.16	224	3.70	0.0302
2021-04-23	2021-03-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,530	-230	-8.33	216	-17.24	0.0318
2021-01-13	2020-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,760	-50	-1.78	261	6.97	0.0395
2020-10-26	2020-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,810	0	0.00	244	-0.41	0.0424
2020-07-17	2020-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,810	0	0.00	245	5.60	0.0490
2020-04-28	2020-03-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,810	0	0.00	232	-12.78	0.0486
2020-01-24	2019-12-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,810	0	0.00	266	9.02	0.0508
2019-10-28	2019-09-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,810	0	0.00	244	-5.06	0.0502
2019-07-12	2019-06-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,810	0	0.00	257	-4.81	0.0528
2019-05-13	2019-03-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,810	160	6.04	270	18.94	0.0584
2019-01-11	2018-12-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,650	0	0.00	227	-0.44	0.0612
2018-10-15	2018-09-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,650	0	0.00	228	14.00	0.0472
2018-07-26	2018-06-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,650	0	0.00	200	-6.54	0.0468
2018-04-09	2018-03-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,650	0	0.00	214	-3.60	0.0514
2018-01-12	2017-12-31	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,650	100	3.92	222	1.37	0.0523
2017-10-12	2017-09-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,550	0	0.00	219	2.82	0.0552
2017-07-19	2017-06-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,550	2,550		213		0.0563
2017-02-03	2016-12-31	13F	NOVARTIS A G	COM	66987V109	0	-2,550	-100.00	0	-100.00
2016-11-18	2016-09-30	13F	NOVARTIS A G	COM	66987V109	2,550	-40	-1.54	201	-6.07	0.0567
2016-08-15	2016-06-30	13F	NOVARTIS	ADR	66987V109	2,590	2,590	-10.07	214	-19.25	0.0622
2016-05-13	2016-03-31	13F	NOVARTIS	ADR	66987V109	0	-2,590	-100.00	0	-100.00
2016-02-01	2015-12-31	13F	NOVARTIS	ADR	66987V109	2,590	-290	-10.07	223	-15.85	0.0674
2015-11-13	2015-09-30	13F	NOVARTIS A G	SPONSORED ADR	66987V109	2,880	0	0.00	265	-6.36	0.0896
2015-08-31	2015-06-30	13F	NOVARTIS	ADR	66987V109	2,880	0	0.00	283	-0.35	0.0773
2015-05-05	2015-03-31	13F	NOVARTIS	ADR	66987V109	2,880	0	0.00	284	6.37	0.0784
2015-02-20	2014-12-31	13F	NOVARTIS	SPONSORED ADR	66987V109	2,880	0	0.00	267	-1.48	0.0697
2014-11-17	2014-09-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,880	0	0.00	271	3.83	0.0737
2014-09-18	2014-06-30	13F	NOVARTIS	SPONSORED ADR	66987V109	2,880	0	0.00	261	6.53	0.0700
2014-06-02	2014-03-31	13F	NOVARTIS	ADR	66987V109	2,880	-1,200	-29.41	245	-25.30	0.0686
2014-02-21	2013-12-31	13F	NOVARTIS	SPON ADR	66987V109	4,080	0	0.00	328	4.79	0.0905
2013-11-26	2013-09-30	13F	NOVARTIS	ADR	66987V109	4,080	281	7.40	313	16.36	0.1018
2013-11-19	2013-06-30	13F	NOVARTIS	ADR	66987V109	3,799	0	0.00	269	-0.74	0.0913
2013-05-21	2013-03-31	13F	NOVARTIS	COM	66987V109	3,799	3,799		271		0.0919

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.